Peter Thompson
InvestorFounderPartner at OrbiMed · Board director at Alpheus Medical · Board director at Prevail Therapeutics · Board director at Sparrow Pharma
Bellevue, Washington
Writes $1M – $75M checks · typically $4M
About
Peter Thompson is a physician-investor and University of Washington neurosurgery professor with 25–30 years of industry and executive experience at Becton Dickinson and Chiron, and serial co-founder/founding CEO of biotechs.
Invests in
AI & Machine LearningBiotechHealthtechMedical Devices
Board director at Alpheus Medical
Intro paths
In turn, Peter can intro founders to Alpheus Medical's investors below.
Alpheus Medical's investors · 3
Co-founders at Alpheus Medical
Board director at Prevail Therapeutics
Intro paths
In turn, Peter can intro founders to Prevail Therapeutics's investors below.
Prevail Therapeutics's investors · 1
Co-founders at Prevail Therapeutics
Board director at Sparrow Pharma
Intro paths
In turn, Peter can intro founders to Sparrow Pharma's investors below.
Sparrow Pharma's investors · 4
Co-founders at Sparrow Pharma
Experience
- Terremoto BiosciencesChairman, Co-Foundercurrent2024 — present
- Terremoto BiosciencesCEO, Co-Founder2021 — 2024
- OrbiMed AdvisorsGeneral Partnercurrent2022 — present
- OrbiMed AdvisorsPartner2013 — 2021San Francisco, New York
- OrbiMed AdvisorsVenture Partner2010 — 2013
- Silverback TherapeuticsCo-Founder, Chairmancurrent2016 — present
- Silverback TherapeuticsCo-Founder, Chairman, CEO2016 — 2020
- Edgewise TherapeuticsChairman, Co-Foundercurrent2017 — presentBoulder, CO
- Corvus PharmaceuticalsCo-Founder, Directorcurrent2014 — present
- Cleave BioSciencesCo-Founder, Directorcurrent2010 — present
- University of WashingtonAffiliate Professor, Neurosurgerycurrent2010 — present
- Principia BiopharmaChairman of the Board2013 — 2019
- Strategicon PartnersCEO, Managing Director2001 — 2013
- Trubion PharmaceuticalsCo-Founder, Chairman, CEO2002 — 2009
- ATP CapitalVenture Partner2002 — 2005
- Chiron CorporationVP, GM Chiron Informatics1995 — 1999
- BDVP, R&D1991 — 1995
- National Cancer InstituteLab Head1985 — 1992
Education
- Brown Medical SchoolM.D., medicine1980 — 1984
- Brown UniversityBachelor's Degree, Molecular Biology1977 — 1981
Skills & more
+12 more
Business StrategyInvestmentsCommercializationScienceR&DBiopharmaceuticalsDue DiligenceStart-upsClinical DevelopmentDrug DevelopmentRegulatory AffairsHealthcareFrom Peter's professional profile.
Deals · 1
Prevail TherapeuticsBoard seat
via OrbiMed · filed Mar 2018 · $65M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at OrbiMed
Frequently asked questions
- Where does Peter Thompson work?
- Peter Thompson is Partner at OrbiMed and Founder at Alpheus Medical and Founder at Prevail Therapeutics and Founder at Sparrow Pharma.
- What does Peter Thompson invest in?
- Peter Thompson invests in AI & Machine Learning, Biotech, Healthtech, Medical Devices.
- What check size does Peter Thompson write?
- Peter Thompson typically writes checks of $1M – $75M.
- What companies did Peter Thompson found?
- Peter Thompson founded Alpheus Medical, Prevail Therapeutics, Sparrow Pharma.
Founder mafias
Brown University mafia109
Also came through, then founded or led a company.
.png)
+ 102 more
OrbiMed mafia6
Also came through, then founded or led a company.
National Cancer Institute mafia5
Also came through, then founded or led a company.
Brown Medical School mafia4
Also came through, then founded or led a company.
Edgewise Therapeutics mafia2
Also came through, then founded or led a company.
Same school
Also attended Brown Medical School4
Also attended Brown University394
.png)
+ 388 more
Shared employers
Also worked at Edgewise Therapeutics2
Also worked at University of Washington89
+ 83 more
Also worked at Principia Biopharma2
Also worked at Chiron Corporation11
+ 5 more